Evidax

Startup

Evidax generates comparative evidence for your asset when head-to-head data are limited.

Your pivotal trial may be single-arm. Or it may be randomised, but not against the treatments patients actually receive in the market you want to enter.

That leaves HTA bodies, payers and clinicians asking important questions your trial was never designed to answer.

Evidax maps the evidence you have against the evidence that stakeholders need to make decisions, identifies exactly what is missing, and generates the evidence to close those gaps. We combine your existing clinical data with published and real-world evidence to build the comparative evidence needed for reimbursement, adoption and market access.

We do this with rigour and speed, combining methodological expertise with purpose-built workflows to deliver decision-ready evidence in weeks, not months.



website

Get involved at World Orphan Drug Congress Europe 2026

 

 

TO SPONSOR


Steph Scanlon

Steph.Scanlon@terrapinn.com

 

TO SPEAK


Abdu Kauroo
Abdu.Kauroo@terrapinn.com

 

MARKETING & PRESS


Jasper Cameron

Jasper.Cameron@terrapinn.com

 

Stay Up-to-Date

Join our mailing list to receive exclusive content and offers.

By submitting, you agree to receive email communications from Terrapinn, including upcoming promotions and discounted tickets and news.